Schedule 13G ownership disclosure
ESPERION THERAPEUTICS, INC.
Security class unavailable · CUSIP: 29664W105
Event date: 2020-06-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,528,101
- Percent of class
- 5.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-20-002409
- Form type
- SC 13G
- Filer
- Esperion Therapeutics, Inc.
- CIK
- CIK 1434868
- Filed
- Jun 15, 2020
- Reporting period
- Jun 03, 2020
- Description
- Schedule 13G beneficial ownership